FRANKFURT (Reuters) -
The race for German generic-drug maker Ratiopharm has practically narrowed to Israel's Teva (TEVA.TA) and U.S. drug major Pfizer (PFE.N), German business daily Handelsblatt reported on Monday. (Ver)
Ver:
Primer Blog "específico" de Marketing Farmacéutico para países de habla hispana.
FRANKFURT (Reuters) -
The race for German generic-drug maker Ratiopharm has practically narrowed to Israel's Teva (TEVA.TA) and U.S. drug major Pfizer (PFE.N), German business daily Handelsblatt reported on Monday. (Ver)
Ver:
“Dum loquimur,
fugerit in vida aetas:
CARPE DIEM
quam minimum credula postero”
“Mientras hablamos,
habrá huido celosa la edad:
goza a bocados del momento,
confía lo menos posible
en el mañana”
No hay comentarios:
Publicar un comentario